CHI’s Screening & Functional Analysis of 3-D Models Conference Set for October 29-30, 2013

Drug R&D Scientists Gather to Discuss Complex Cellular Models Predictive of Human Response to Improve Early Decision Making
 
NEEDHAM, Mass. - July 17, 2013 - PRLog -- Cambridge Healthtech Institute (CHI) released the final agenda for its Inaugural Screening & Functional Analysis of 3-D Models conference being held on October 29-30, 2013 at Le Méridien Cambridge-MIT in Cambridge, MA. The conference will explore how to use 3-D models to profile compound action and predict toxicity and efficacy. The meeting will cover assay development using 3-D cellular models, high-content analysis and imaging of 3-D models, and applications of screening 3-D models for compound profiling and target discovery/validation from 18 prominent scientists:

Anne Bang, Ph.D., Sanford-Burnham Medical Research Institute
Geoffrey A. Bartholomeusz, Ph.D., University of Texas MD Anderson Cancer Center
Sylvain Costes, Ph.D., Lawrence Berkeley National Laboratory
Anthony M. Davies, Ph.D., Irish National Center for High-Content Screening and Analysis (INCHA)
Eugen Dhimolea, Ph.D., Harvard Medical School
Jonathan Dordick, Ph.D., Rensselaer Polytechnic Institute
Marina Fitzek, AstraZeneca
Bumsoo Han, Ph.D., Purdue University
Mitchell Ho, Ph.D., NIH
Daniel V. LaBarbera, Ph.D., University of Colorado
Lisa Minor, Ph.D., In Vitro Strategies, LLC
Aaron Morris, Ph.D., Sanofi Oncology
Michelle Palmer, Ph.D., Broad Institute
Nathalie Picollet-D’Hahan, Ph.D., Biomics
Fredika M. Robertson, Ph.D., University of Texas MD Anderson Cancer Center
Caroline Shamu, Ph.D., Harvard Medical School
D. Lansing Taylor, Ph.D., University of Pittsburgh
Adina Vultur, Ph.D., Wistar Institute

View the full agenda and register at www.fastcongress.com/Analysis-of-3D-Models.

Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi, lscimemi@healthtech.com.

This conference is part of FAST: Functional Analysis & Screening Technologies Congress (Oct. 28-30).

About Cambridge Healthtech Institute (chicorporate.com)

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations.  Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
End
Source: » Follow
Email:***@healthtech.com Email Verified
Tags:Drug Screening, Drug R&d, Assays
Industry:Science, Biotech
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share